ZyVersa Therapeutics, Inc. financial data

Symbol
ZVSA on Nasdaq
Industry
Pharmaceutical Preparations
Location
217 W. Main Street, Somerville, NJ
State of incorporation
DE
Fiscal year end
December 31
Former names
Larkspur Health Acquisition Corp. (to 12/9/2022)
Latest financial report
10-K - Q4 2024 - Mar 27, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 13.3 % -41.3%
Debt-to-equity 129 % +254%
Return On Equity -106 % +60%
Return On Assets -46.4 % +76.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 2.57M shares -66.2%
Common Stock, Shares, Outstanding 2.51M shares +524%
Entity Public Float 3.1M USD -44.6%
Common Stock, Value, Issued 251 USD +528%
Weighted Average Number of Shares Outstanding, Basic 1.11M shares +1038%
Weighted Average Number of Shares Outstanding, Diluted 1.11M shares +1038%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 1.78M USD -44.5%
General and Administrative Expense 7.36M USD -34.4%
Operating Income (Loss) -9.14M USD +91.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -9.41M USD +91.3%
Income Tax Expense (Benefit) 9.71K USD
Net Income (Loss) Attributable to Parent -9.41M USD +90.4%
Earnings Per Share, Basic -8.48 USD/shares +99.2%
Earnings Per Share, Diluted -8.48 USD/shares +99.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets, Current 1.72M USD -48.8%
Property, Plant and Equipment, Net 1.73K USD -85.7%
Operating Lease, Right-of-Use Asset 7.84K USD -92%
Intangible Assets, Net (Excluding Goodwill) 30.8M USD
Goodwill 11.9M USD
Other Assets, Noncurrent 18.6M USD 0%
Assets 20.6M USD -6.85%
Accounts Payable, Current 9.34M USD +10.7%
Accrued Liabilities, Current 1.89M USD +7.95%
Liabilities, Current 11.2M USD +10.2%
Deferred Income Tax Liabilities, Net 852K USD +0.8%
Liabilities 12.1M USD +9.45%
Retained Earnings (Accumulated Deficit) -113M USD -9.12%
Stockholders' Equity Attributable to Parent 8.52M USD -23.1%
Liabilities and Equity 20.6M USD -6.85%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.78M USD +17.7%
Net Cash Provided by (Used in) Financing Activities 2.67M USD
Common Stock, Shares Authorized 250M shares 0%
Common Stock, Shares, Issued 2.51M shares +519%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.1M USD +76.1%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.53M USD -51.2%
Deferred Tax Assets, Valuation Allowance 16M USD +13.2%
Deferred Tax Assets, Gross 19.8M USD +10.5%
Depreciation 2.6K USD 0%
Lessee, Operating Lease, Liability, to be Paid 8.66K USD -92%
Property, Plant and Equipment, Gross 52K USD 0%
Operating Lease, Liability, Current 8.66K USD -92%
Lessee, Operating Lease, Liability, to be Paid, Year One 8.7K USD -92.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 48 USD -98.8%
Deferred Tax Assets, Operating Loss Carryforwards 12.5M USD +25.8%
Preferred Stock, Shares Authorized 1M shares 0%
Operating Lease, Payments 8.66K USD -64.3%
Additional Paid in Capital 121M USD +6%
Deferred Tax Assets, Net of Valuation Allowance 3.82M USD +0.62%
Share-based Payment Arrangement, Expense 706K USD -40.9%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%